NeuroTherapia, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neurotherapia.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)A Study of NTRX-07 in Participants With Alzheimer's Disease
Not Applicable
Recruiting
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- NeuroTherapia, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT07058688
- Locations
- 🇨🇿
Neuro Health Centrum s.r.o., Brno, Czechia
🇨🇿Neuropsychiatrie s.r.o., Prague, Czechia
🇭🇺Semmelweis University, Budapest, Hungary
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- NeuroTherapia, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06194552
- Locations
- 🇺🇸
NeuroTherapia, Gates Mills, Ohio, United States
🇭🇺CRU Early Phase Unit Kistarcsa, Kistarcsa, Hungary
Safety and Tolerability of NTRX-07 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pain, Neuropathic
- Interventions
- Drug: NTRX-07-SDD
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- NeuroTherapia, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04375436
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
News
No news found